We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 693

Connecticut requires pre-acquisition notice of physician practices and hospitals

  • McGuireWoods LLP
  • -
  • USA
  • -
  • October 20 2014

Effective October 1, 2014, Connecticut requires prior notification of any transaction that will result in a material change of the business or

Connecticut is latest state to expand healthcare antitrust enforcement

  • Proskauer Rose LLP
  • -
  • USA
  • -
  • October 15 2014

Under new Connecticut healthcare legislation, which took effect October 1, 2014, parties to transactions that result in a "material change to the

Provider competition matterseven for “reference pricing”

  • Baker & Hostetler LLP
  • -
  • USA
  • -
  • October 9 2014

In a recent blog post, three Federal Trade Commission (FTC) economists splashed some cold water on advocates of “reference pricing” that seem to

New York AG accuses pharmaceutical companies of product hopping

  • McGuireWoods LLP
  • -
  • USA
  • -
  • October 7 2014

On September 15, in New York v. Actavis PLC et al., New York State Attorney General Eric Schneiderman filed an antitrust suit against Actavis PLC and

Will Namenda IR withdrawal force a legal switch on product hopping?

  • Fenwick & West LLP
  • -
  • USA
  • -
  • October 3 2014

On September 15, 2014, New York Attorney General Eric Schneiderman filed an anti-trust lawsuit against the specialty pharmaceutical company Forest

Health Law Insight September 2014 State update New York

  • McCarter & English LLP
  • -
  • USA
  • -
  • October 2 2014

New York State’s Department of Health proposed regulations for entities to obtain a Certificate of Public Advantage (COPA) under Public Health Law

Sham-wow! antitrust liability may attach to sham administrative petitions

  • McDermott Will & Emery
  • -
  • USA
  • -
  • October 1 2014

Addressing whether the “sham” exception to Noerr-Pennington immunity is limited to sham litigation in courts, the U.S. Court of Appeals for the

FTC continues aggressive scrutiny of hospital mergers

  • King & Spalding LLP
  • -
  • USA
  • -
  • September 22 2014

A recent New York Times article highlighted new developments regarding the Federal Trade Commission's (FTC) continued focus on hospital mergers

Fair play?

  • Pillsbury Winthrop Shaw Pittman LLP
  • -
  • USA
  • -
  • September 20 2014

With blockbuster drugs reaching the end of their patent lives, many companies are looking for new ways to best secure their formulations and protect

FTC doubles down in challenge to pharmaceutical settlement

  • Skadden Arps Slate Meagher & Flom LLP
  • -
  • USA
  • -
  • September 10 2014

On September 8, 2014, the Federal Trade Commission (FTC) filed a federal antitrust complaint in the United States District Court for the Eastern